Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes
by Delthia Ricks , Medical XpressTeplizumab delays type 1 diabetes (T1D) in at-risk individuals in TN10 trial, but participants respond differently to the treatment. Systemic, non-pathogenic antibody
Updated on: March 14,2024
20
Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes
by Delthia Ricks , Medical XpressTeplizumab delays type 1 diabetes (T1D) in at-risk individuals in TN10 trial, but participants respond differently to the treatment. Systemic, non-pathogenic antibody
Updated on:March 14,2024
20